Bayer CEO Says Breakup Wouldn’t Fix All of the Company’s Ills

[ad_1] BERLIN—Bayer Chief Executive Bill Anderson said the company would bounce back quickly from a recent spate of bad news, and warned that a breakup of the pharmaceutical and agricultural…

Alibaba Scraps Cloud Unit Spinoff, Citing Washington’s Chip Curbs

[ad_1] Updated Nov. 16, 2023 8:41 pm ET SINGAPORE—Washington’s latest curbs on the export of high-performance chips to China are beginning to bite. Alibaba on Thursday said it had scrapped…

Alibaba’s Spinoff Plans Fall to Earth

[ad_1] Alibaba’s shareholders finally got their first dividend. But that may not be enough to compensate for hiccups in its spinoff plan and slowing growth. The Chinese e-commerce giant on…

Wuxi Biologics Unit’s Hong Kong IPO Closes Order Book a Day Early, Sources Say

[ad_1] A unit of Chinese contract drugmaker Wuxi Biologics closed its order book a day early for its initial public offering and is likely to price the deal at the…

GE Healthcare Discloses Potential Foreign Bribery Violations in China

[ad_1] General Electric spinoff GE HealthCare Technologies said it reported potential foreign bribery violations in some of its operations in China to U.S. regulators.  GE HealthCare found “tender irregularities and…

Sanofi Plans to Spin Off Consumer-Healthcare Business

[ad_1] Sanofi said it plans to spin off its consumer-healthcare unit into a publicly listed entity, making it the latest pharmaceutical giant to sharpen its focus on prescription medicines by…

Zodia Markets CEO Ahmad backs stablecoins for growth after crypto crash

[ad_1] The chief executive of Standard Chartered’s crypto offshoot Zodia Markets Usman Ahmad is looking to cash in on surging global demand for stablecoins. “A lot of corporate clients are interested…

Kellogg’s Plans for Stranded Cereal Unit Look Soggy

[ad_1] In its eagerness to focus on snacks, Kellogg hasn’t provided a convincing growth plan for its cereal spinoff. [ad_2] Source link

Johnson & Johnson Posts Higher Quarterly Sales, Raises 2023 Outlook

[ad_1] First-quarter earnings were largely wiped out by a $6.9 billion charge tied to litigation and other costs from its Covid-19 vaccine commitments. [ad_2] Source link

Seven & I Board Opposes ValueAct’s Proposal to Remove CEO, Other Directors

[ad_1] Seven & i Holdings said its board would oppose a proposal made by San Francisco-based activist investor ValueAct Capital LP to replace board members, including Chief Executive Ryuichi Isaka.…